Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoxygenase homology domain-containing protein 1 (LOXHD1) is a highly conserved protein composed entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, implicated in the targeting of proteins to the plasma membrane[1][3]. It is critically expressed in the mechanosensory hair cells of the inner ear, where it is required for their normal function. Mutations in the LOXHD1 gene cause DFNB77, a progressive autosomal-recessive nonsyndromic hearing loss, illustrating its essential role in auditory physiology[1][5]. Alternative splicing of this gene generates different isoforms, but its established physiological and pathological relevance is confined to hair cell function and auditory disorders, not as a typical drug target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoxygenase homology domain-containing protein 1 (LOXHD1).